| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
0.263 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.263 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
LRP1 |
LRP1, A2MR, APR: Prolow-density lipoprotein receptor-related protein 1 precursor |
0.263 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
CD63 |
CD63, MLA1, TSPAN30: CD63 antigen |
0.263 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
GMIP |
GMIP: GEM-interacting protein |
0.263 |
Evidence |
|
| ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
CTGF |
CTGF, CCN2, HCS24: Connective tissue growth factor precursor |
0.263 |
Evidence |
|
| ITGAV |
ITGAV, MSK8, VNRA: Integrin alpha-V precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
0.263 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
C7 |
C7: Complement component C7 precursor |
0.263 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
LPA |
LPA: Apolipoprotein(a) precursor |
0.263 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
USP10 |
USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 |
0.263 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
0.263 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
DOK1 |
DOK1: Docking protein 1 |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SNX17 |
SNX17, KIAA0064: Sorting nexin-17 |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.263 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
0.263 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
0.263 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.263 |
Evidence |
|